Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds virus or component thereof
Patent
1995-01-27
1996-12-10
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds virus or component thereof
4241301, 5303894, 435 5, 435 79, 435 792, A61K 3942
Patent
active
055828272
ABSTRACT:
A process for identifying plasma samples containing effective antibody titers for the treatment and/or prophylaxis of infections caused by a respiratory virus. The process comprises contacting a plasma sample containing antibodies against a respiratory virus with the respiratory virus. The mixture of plasma sample and virus is then contacted with a plurality of cells. The remaining non-neutralized virus in the sample is then determined through an immunoassay following replication of the virus in the cells. Plasma samples which, at a preselected minimum antibody titer value, prevent viral replication in the cells, are then selected. Plasma from which the selected samples were derived are then pooled to provide an immunoglobulin preparation having increased effectiveness in the prophylaxis and/or treatment of infections caused by the respiratory virus.
REFERENCES:
patent: 4617379 (1986-10-01), Dobkin et al.
patent: 4665379 (1987-05-01), Dobkin
patent: 4717766 (1988-01-01), Dobkin
patent: 4800078 (1989-01-01), Prince et al.
patent: 5412077 (1995-05-01), Siber et al.
Anderson, et al., J. Clin. Microbiol., vol. 22, No. 6, pp. 1050-1052 (Dec. 1975).
Yolken, Rev. Infect. Dis., vol. 4, No. 1, pp. 35-59 (Jan.-Feb. 1982).
Tijssen, "Practice and Theory of Enzyme Immunoassays", Elsevier, New York, pp. 358-362 (1985).
Leszczynski Jeanne
Siber George R.
Massachusetts Health Research Institute, Inc.
Nucker Christine M.
Olstein Elliot M.
Stucker Jeffrey
LandOfFree
Process of screening plasma samples for effective antibody titer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process of screening plasma samples for effective antibody titer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process of screening plasma samples for effective antibody titer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-422167